July 27, 2023: MGMA and coalition partners endorse Value in Health Care Act of 2023

July 27, 2023   

Dear Representatives LaHood, DelBene, Wenstrup, Blumenauer, Bucshon and Schrier:

On behalf of the undersigned organizations, we thank you for your leadership in supporting value-based health care. We write to endorse the Value in Health Care Act of 2023. This bipartisan legislation makes several important reforms to ensure that alternative payment models (APMs) continue to produce high quality care for the Medicare program and its beneficiaries.

In the last decade, some APMs have generated billions of dollars in savings for taxpayers all while maintaining quality of care for patients. The growth of APMs may have also produced a “spill-over” effect on care delivery across the nation, potentially slowing the overall rate of growth of health care spending. The Congressional Budget Office (CBO) reported earlier this year that actual Medicare and Medicaid spending between 2010–2020 was 9 percent lower than original projections, with improvements to care management and more efficient use of technology playing a role in slowing spending on federal health programs.

A key aim of the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) was to speed the transition to patient-centered, value-based care by encouraging physicians and other clinicians to transition into APMs. While MACRA was a step in the right direction, the transition has been slower than anticipated and more needs to be done to drive long-term system transformations. The Value in Health Care Act helps maintain and further strengthen the movement towards high-quality care in which financial performance is linked to the quality of patient care rather than the number of services delivered.

View the full letter